±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 645  |  »Ø¸´: 9
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

qiuzhen3602

Í­³æ (СÓÐÃûÆø)

[½»Á÷] Ͷ¸åÇóÖú

´ó¼Ò°ï°ï棬¿´¿´±à¼­µÄÐÅ:
Reviewers' comments on your work have now been received.

Based on these comments we regret to inform you that we must reject this paper from further consideration for publication. In addition to the comments shown below, all reviewers indicated that the originality and overall priority of the manuscript are low. Due to the large number of submitted manuscripts only papers with high priority can be published.
We suggest that you use the reviewers´ comments as a guide if you prepare this manuscript for submission to another journal.
ͶµÄÔÓÖ¾ÊÇEuropean Journal of Pharmaceutical Sciences£¬ÈýλÉó¸åÈËÌáÁ˺ܶàÎÊÌ⣬¸öÈËÈÏΪ¶¼²»ÊÇÊ²Ã´ÖØ´óÎÊÌ⣬×ܽáÆðÀ´´ó²¿·Ö¶¼ÊÇÎÄÕµÄһЩÄÚÈݽ»´úµÄ²»ÊǺÜÇå³þ£¬ÓïÑÔÐèÒªÔÙÕå×á£Éó¸åÈ˵Ĵ󲿷ÖÎÊÌâÎÒ¶¼¿ÉÒÔ¼ÓÒÔ½âÊͺÍÐ޸ģ¬ÎÒ»¹ÏëÔÙͶ¸ÃÔÓÖ¾£¬´ó¼Ò¸øµãÒâ¼û£¬¿ÉÐÐÂ𣿾õµÃ»áÓкÃÏûÏ¢Âð£¿ÕâÊDZ¾È˵ÚÒ»´ÎͶ¸å£¬ÕûÌìÌáÐĵõµ¨µÄ¡£¸÷λ´óÏÀ¸Ï¿ì¾È¾ÈÎÒ°É¡£
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

»¨·É·É

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Â¥Ö÷×ÐϸÐ޸ģ¬Ò»Ò»»Ø¸´ÈýλÉó¸åÈË£¬½¨Ò黹ÊÇͶÕâ¸öÔÓÖ¾£¬»¹ÊÇÓлú»áµÄ
ûÓÐÉ¡µÄº¢×Ó±ØÐëŬÁ¦±¼ÅÜ
3Â¥2010-03-11 10:50:44
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 10 ¸ö»Ø´ð

Ñà¹Âºè

½ð³æ (ÖøÃûдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
ÎÒ½¨ÒéÄ㻻Ͷ±ðµÄÆÚ¿¯£¬ÒòΪ¾Ü¾øÄãµÄÔ­ÒòÊÇÕâ¸ö

all reviewers indicated that the originality and overall priority of the manuscript are low.
ÈËÈôÎÞÃû,±ã¿ÉרÐÄ
2Â¥2010-03-11 10:48:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yf0534

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
±à¼­ËµµÄºÜÇå³þÁË£¬ËµÂ¥Ö÷µÄÎÄÕµµ´Î²»¹»£¬¶øÇÒͶ¸Ã¿¯ÎïµÄÎÄÕºܶ࣬¥Ö÷»¹ÊǸÄͶÆäËû¿¯Îï±È½ÏºÃ£¬
4Â¥2010-03-11 10:50:50
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

chemkun

Òø³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
×îºÃ»¹ÊÇͶµÝ±ðµÄÔÓÖ¾°É£¬ÎÒͶµÝ¹ýÔÙͶ»¹ÊDZ¯¾ç
ÉúΪ»¯Ñ§ÈË£¬ËÀÒ໯ѧ¹í
5Â¥2010-03-11 10:53:06
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ±¾¿Æ211£¬293·ÖÇëÇóµ÷¼Á +7 Á«²Ë¾ÍÊÇź°É 2026-04-03 8/400 2026-04-05 11:41 by arrow8852
[¿¼ÑÐ] 271·ÖÇóµ÷¼ÁѧУ +12 zph158488£¡ 2026-04-02 13/650 2026-04-05 10:13 by lqwchd
[¿¼ÑÐ] 304Çóµ÷¼Á£¨085602£¬¹ýËļ¶£¬Ò»Ö¾Ô¸985£© +12 »¯¹¤ÈË999 2026-04-04 12/600 2026-04-05 09:15 by sam3303
[¿¼ÑÐ] 288»·¾³×¨Ë¶,Çóµ÷²ÄÁÏ·½Ïò +13 lllllos 2026-04-04 14/700 2026-04-04 23:34 by lqwchd
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +15 Ò»ÑùYWY 2026-04-01 15/750 2026-04-04 22:23 by hemengdong
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÄÏʦ·¶361·Ö£¬»¯Ñ§Çóµ÷¼Á +7 Nicole88888 2026-04-01 7/350 2026-04-04 18:28 by macy2011
[¿¼ÑÐ] Ò»Ö¾Ô¸0817»¯Ñ§¹¤³ÌÓë¼¼Êõ£¬Çóµ÷¼Á +24 ÎÒ²»ÊÇÖ»Òò 2026-04-02 28/1400 2026-04-04 15:15 by dongzh2009
[¿¼ÑÐ] ѧ˶»úе¹¤³Ì303Çóµ÷¼Á +6 ÎÞÃûËùÒÔ½ÐÎâÃ÷ 2026-03-30 7/350 2026-04-03 16:48 by asdfzly
[¿¼ÑÐ] Çó²ÄÁϵ÷¼Á Ò»Ö¾Ô¸Äϲý´óѧ 328·Ö +5 yyy..... 2026-04-03 5/250 2026-04-03 13:46 by °ÙÁéͯ888
[¿¼ÑÐ] Çóµ÷¼Á +9 akdhjs 2026-03-31 11/550 2026-04-03 13:32 by akdhjs
[¿¼ÑÐ] 274Çóµ÷¼Á +10 Ѧ¶¨Ú̵Ļ¢¡£ 2026-04-01 10/500 2026-04-03 10:13 by tianyyysss
[¿¼ÑÐ] 279Çóµ÷¼Á +5 ¸µÎÄÇï 2026-04-02 5/250 2026-04-02 18:10 by ±ÊÂä½õÖÝ
[¿¼ÑÐ] 08ÉúÎïÓëҽҩר˶³õÊÔ346ÕÒµ÷¼Á +6 dianeeee 2026-04-01 7/350 2026-04-02 08:23 by guoweigw
[¿¼ÑÐ] °²È«¹¤³Ì 285 Çóµ÷¼Á +3 Xinyu56 2026-04-01 4/200 2026-04-01 21:50 by ¾²¾²¾²¾²¾²¾²¾²¾
[¿¼ÑÐ] 310·ÖÇóµ÷¼Á +4 ³É¹¦Éϰ¶wang 2026-04-01 4/200 2026-04-01 20:35 by liu823948201
[¿¼ÑÐ] »·¾³¹¤³Ìµ÷¼Á +9 hyzzzzzzz. 2026-04-01 9/450 2026-04-01 14:20 by salamander`
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +10 Eujd1 2026-03-31 11/550 2026-04-01 11:23 by ivanqyq
[¿¼ÑÐ] 326Çóµ÷¼Á +4 áÌáÌ×Ð 2026-03-31 4/200 2026-04-01 09:58 by ÎҵĴ¬Îҵĺ£
[¿¼ÑÐ] 289Çóµ÷¼Á +7 BrightLL 2026-03-29 7/350 2026-03-31 22:05 by 544594351
[¿¼ÑÐ] 323·Ö ʳƷÓëÓªÑøµ÷¼Á +3 ºÙooo 2026-03-31 3/150 2026-03-31 09:38 by longlotian
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û